SCHEMBL14211019

SCHEMBL14211019

Cc1ccc(NC(=O)C(C)(C)C)cc1[N+](=O)[O-]

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.65
RAB9A P51151 5/20 0.65
NPC1 O15118 4/20 0.65
MAPK1 P28482 3/20 0.65
LMNA P02545 2/20 0.65
ATM Q13315 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
KMT2A Q03164 8/20 0.63
SMN1; SMN2 Q16637 6/20 0.63
MEN1 O00255 6/20 0.63
HPGD P15428 4/20 0.58
PPIA P62937 1/20 0.57
HTT P42858 1/20 0.54
ALDH1A1 P00352 2/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
IDH1 O75874 1/20 0.53
PGR P06401 1/20 0.52
CYP3A4 P08684 1/20 0.52
AR P10275 1/20 0.52
ALOX12 P18054 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14466025 0.88 RAB9A (0.62) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL2312502 0.84 KMT2A (0.75) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL11326938 0.84 KMT2A (0.85) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL2312499 0.84 KMT2A (0.75) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL3977028 0.84 LMNA (0.62) MAPTRAB9AMAPK1LMNAKMT2A
SCHEMBL2979815 0.84 MAPT (0.52) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL7600834 0.83 ALDH1A1 (0.72) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL30483195 0.83 ALDH1A1 (0.72) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL5530308 0.81 KMT2A (0.67) MAPTRAB9ANPC1MAPK1LMNA
SCHEMBL2011026 0.81 AR (0.66) MAPK1LMNASMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140343098-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-11-20 US disclosed
US-8802700-B2 Modulators of ATP-Binding Cassette transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-12 US disclosed
US-20130165442-A1 Modulators of ATP-Binding Cassette Transporters VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-06-27 US disclosed
US-20120309758-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165442-A1 Modulators of ATP-Binding Cassette Transporters CFTR, ABCB1, ABCC2 MAPT 4269/4885RAB9A 2557/4885NPC1 28/4885
US-20140343098-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 MAPT 4269/4885RAB9A 2557/4885NPC1 28/4885
US-20120309758-A1 MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS CFTR, ABCB1, ABCC2 MAPT 4269/4885RAB9A 2557/4885NPC1 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.